Anixa Biosciences
ANIX
ANIX
45 hedge funds and large institutions have $9.95M invested in Anixa Biosciences in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.23% less ownership
Funds ownership: 10.96% → 10.73% (-0.23%)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
Holders
45
Holding in Top 10
–
Calls
$151K
Puts
$45K
Top Buyers
| 1 | +$158K | |
| 2 | +$110K | |
| 3 | +$76.6K | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$76.4K |
| 5 |
LPL Financial
San Diego,
California
|
+$69K |
Top Sellers
| 1 | -$438K | |
| 2 | -$80K | |
| 3 | -$42.4K | |
| 4 |
US Bancorp
Minneapolis,
Minnesota
|
-$41.8K |
| 5 |
Morgan Stanley
New York
|
-$40.5K |